Table 3.
Quality of evidence in included systematic reviews and meta-analyses with Grading of Recommendations Assessment, Development, and Evaluation.
References | Outcomes | Limitations | Inconsistency | Indirectness | Imprecision | Publication bias | Quality of evidence | |
---|---|---|---|---|---|---|---|---|
Guo et al. (2008) | EA vs. Nimodipine | General effective | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Lee et al. (2008) | EA vs. Nimodipine/Huperzine/ Perphenazine | MMSE | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low |
EA vs. Nimodipine/Huperzine/ Perphenazine | ADL | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low | |
Zhu and Zhang (2009) | EA vs. Nimodipine/Duxil | General effective | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low |
Yuan and Zhang (2010) | Before and after acupuncture | MMSE | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Liu et al. (2011) | Acupuncture + Nimodipine/Donepezil/Duxil vs. Nimodipine/Donepezil/Duxil | General effective | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Cao et al. (2013) | Acupuncture + CFT vs. WM/CFT | MMSE | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Fang et al. (2014) | Acupuncture + CFT vs. CFT | MMSE | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Zhao et al. (2014) | EA/ Acupuncture/SA + CFT/ Nimodipine vs. CFT | General effective | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Acupuncture vs. CFT | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Acupuncture vs. CFT | ADL | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low | |
Cao et al. (2014) | Acupuncture vs. Nimodipine/Donepezil/Duxil | MMSE | Seriousa | Seriousb | Not serious | Not serious | Seriousc | Very low |
Acupuncture vs. Nimodipine/Donepezil/Duxil | ADL | Seriousa | Seriousb | Not serious | Not serious | Seriousc | Very low | |
Hu et al. (2014) | Acupuncture vs. Nimodipine | General effective | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Acupuncture vs. Nimodipine | MMSE | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate | |
Zhou et al. (2015) | Acupuncture vs. Nimodipine | MMSE | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Acupuncture vs. Nimodipine | ADL | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate | |
Mai and Zheng (2015) | EA vs. CFT | General effective | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low |
EA vs. CFT | MMSE | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low | |
EA vs. CFT | MoCA | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low | |
Lu et al. (2015) | Acupuncture + CT vs. CT | General effective | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low |
Acupuncture + CT vs. CT | MMSE | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low | |
Acupuncture + CT vs. CT | ADL | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Zhang et al. (2015) | Acupuncture + CFT vs. CFT | General effective | Seriousa | Seriousb | Not serious | Not serious | Seriousc | Very low |
Acupuncture + CFT vs. CFT | MMSE | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate | |
Acupuncture + CFT vs. CFT | ADL | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate | |
Xu and Xie (2015) | BA + Nimodipine vs. Nimodipine | General effective | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
BA + Nimodipine vs. Nimodipine | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Deng and Wang (2016) | SEA vs. Nimodipine | General effective | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low |
SEA vs. Nimodipine | MMSE | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low | |
Xiong et al. (2016) | SA + CT vs. CT | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low |
Lin et al. (2016) | Acupuncture vs. CT | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low |
Acupuncture vs. CT | ADL | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate | |
Acupuncture vs. CT | MoCA | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low | |
Zou et al. (2016) | Acupuncture vs. Huperzine/Nimodipine | General effective | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Acupuncture vs. Huperzine/Nimodipine | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Acupuncture vs. Huperzine/Nimodipine | ADL | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Acupuncture vs. Huperzine/Nimodipine | HDS | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Zhou et al. (2017) | Acupuncture + HM vs. Huperzine/Hydergine/Donepezil | General effective | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Acupuncture + HM vs. Huperzine/Hydergine/Donepezil | MMSE | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate | |
Acupuncture + HM vs. Huperzine/Hydergine/Donepezil | ADL | Seriousa | Seriousb | Not serious | Not serious | Seriousc | Very low | |
Wan et al. (2017) | EA vs. Nimodipine | General effective | Seriousa | Seriousb | Not serious | Not serious | Seriousc | Very low |
EA vs. Nimodipine | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
EA vs. Nimodipine | ADL | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low | |
Zhan et al. (2017) | EA + Nimodipine/CFT vs. Nimodipine | General effective | Seriousa | Seriousb | Not serious | Not serious | Seriousc | Very low |
EA + Nimodipine/CFT vs. Nimodipine CFT | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
EA + Nimodipine/CFT vs. Nimodipine/CFT | MoCA | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Lin et al. (2017) | Acupuncture vs. TCM | General effective | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low |
Acupuncture vs. TCM | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Kwon et al. (2018) | AA vs. Nimodipine/Almitrine-Raubasine | MMSE | Seriousa | Seriousb | Not serious | Not serious | Seriousc | Very low |
AA vs. Nimodipine/Almitrine-Raubasine | ADL | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low | |
AA + HM vs. HM | MMSE | Seriousa | Seriousb | Not serious | Not serious | Seriousc | Very low | |
Wu et al. (2018) | EA vs. Nimodipine | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low |
EA vs. Nimodipine | ADL | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Liu et al. (2018) | EA + CT + CFT vs. CT+CFT | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low |
Li et al. (2018) | Acupuncture + Nimodipine vs. Nimodipine | General effective | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low |
Acupuncture + Nimodipine vs. Nimodipine | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Acupuncture + Nimodipine vs. Nimodipine | ADL | Seriousa | Seriousb | Not serious | Not serious | Seriousc | Very low | |
Acupuncture + Nimodipine vs. Nimodipine | MoCA | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Kim et al. (2019) | EA vs. Nimodipine/Donepezil | MMSE | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
EA vs. Nimodipine/Donepezil | MoCA | Seriousa | Not serious | Not serious | Not serious | Seriousc | Low | |
Wang et al. (2019) | EA vs. Donepezil/Huperzine | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low |
EA vs. Donepezil/Huperzine | ADL | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Li et al. (2020) | Acupuncture + Nimodipine/Donepezil vs. Nimodipine/Donepezil | General effective | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Acupuncture + Nimodipine/Donepezil vs. Nimodipine/Donepezil | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Acupuncture + Nimodipine/Donepezil vs. Nimodipine/Donepezil | MoCA | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low | |
Acupuncture + Nimodipine/Donepezil vs. Nimodipine/Donepezil | ADL | Seriousa | Seriousb | Not serious | Not serious | Seriousc | Low | |
Wang et al. (2020) | Acupuncture/EA vs. Nimodipine/Donepezil/Huperzine | MMSE | Seriousa | Seriousb | Not serious | Not serious | Not serious | Low |
Acupuncture/EA vs. Nimodipine/Donepezil/Huperzine | ADL | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate | |
Acupuncture/EA vs. Nimodipine/Donepezil/Huperzine | HDS | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate | |
Tang et al. (2020) | Acupuncture vs. CFT (on post-operative day 7) | Incidence of POCI | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
Acupuncture vs. CFT (on post-operative day 7) | MMSE | Seriousa | Not serious | Not serious | Not serious | Not serious | Moderate |
The design of the experiment with a large bias in random, distributive hiding or blind; bThe confidence interval overlaps less, the heterogeneity test P is very small, and the I2 is larger; cFewer studies are included, and there may be greater publication bias.